LEHI, Utah, June 12, 2025 /PRNewswire/ — Biolexis Therapeutics, Inc. (www.biolexistx.com), a clinical-stage therapeutics company pioneering next-generation treatments for metabolic and muscle-wasting diseases, today announced the initiation of Phase I clinical trials for its lead GLP-1…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
Patients in the tri-state region of Louisiana, Arkansas, and Texas can now benefit from the first FDA marketing authorized, battery-free tibial neuromodulation implant for patients with Urge Urinary Incontinence PARK CITY, Utah, Dec. 21, 2023 […]
National Fitness Franchise Begins the New Year with Expansion into New States CHARLOTTE, N.C., Jan. 23, 2025 /PRNewswire/ — Burn Boot Camp, a leader in the fitness industry, is proud to announce a major milestone […]
Selarom Plastic Surgery, under the guidance of Dr. Rod Schmelzer, is recognized as the premier destination for breast implant surgery in Salt Lake City, Utah. Dr. Schmelzer, a board-certified surgeon offers personalized care in a […]
Copyright © 2026 Biotech Networks
